A DEA judge has paused the hearing on moving all marijuana to Schedule III while he decides whether to admit a GAO report on gaps in federal scheduling procedures. Also this week: New Mexico advocates push back on the medical psilocybin program’s certifying-clinician rule, Oregon’s psilocybin program faces a $3.8 million shortfall, and ARPA-H launches SURPASS.
The post Weekly Psychedelic Policy Briefing: October 5, 2026 appeared first on Psychedelics Today.
